• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转移至肝脏的嫌色细胞肾细胞癌嗜酸性变:诊断陷阱。

Eosinophilic variant of chromophobe renal cell carcinoma metastasizing to the liver: Diagnostic pitfall.

作者信息

Inoue Daisuke, Oura Shoji

机构信息

Department of Surgery, Kishiwada Tokushukai Hospital, Kishiwada-city, Osaka, 596-8522 Japan.

出版信息

Radiol Case Rep. 2023 Jul 27;18(10):3504-3508. doi: 10.1016/j.radcr.2023.07.006. eCollection 2023 Oct.

DOI:10.1016/j.radcr.2023.07.006
PMID:37560153
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10407264/
Abstract

An 82-year-old man developed a hypervascular renal tumor, 2 cm in size, and multiple liver tumors. Liver tumors had obscured tumor margins on ultrasonography. Positron emission tomography/computed tomography (PET/CT) showed no areas of avid radiotracer uptake in the liver. Routine pathological examination failed to demonstrate tumor cells in 9 tissue samples obtained from repeated core needle biopsies. Even a frozen section of the liver segment 8 tumor further failed to prove malignant cells, and an additive frozen section of the liver section 2 tumor finally proved atypical cells growing in tubular and solid fashions with eosinophilic cytoplasm. Tumors showed expansive growth patterns, were in direct contact with normal liver cells, had abundant micro-vessels, had only sparse hyalinized septa, and had no pale cells. Immunostaining revealed the tumor cells to be positive for CD10, CD117, and E-cadherin and negative for CK7, and PAX8, leading to the diagnosis of metastatic chromophobe renal cell carcinoma (chRCC) in the liver. Arginase-1 immunostaining clearly demarcated the boundary between the chRCC cells and normal hepatic cells. Diagnostic physicians should note that chRCCs are of low-grade malignancy despite their abundant intra-tumoral blood flow and can often pose imaging and pathologic diagnostic difficulties.

摘要

一名82岁男性出现了一个大小为2厘米的富血管性肾肿瘤以及多个肝肿瘤。超声检查显示肝肿瘤使肿瘤边界模糊不清。正电子发射断层扫描/计算机断层扫描(PET/CT)显示肝脏中没有放射性示踪剂摄取增加的区域。对重复进行的粗针活检获取的9份组织样本进行常规病理检查,均未发现肿瘤细胞。即使对肝8段肿瘤进行冰冻切片检查,也未能进一步证实存在恶性细胞,而对肝2段肿瘤进行的补充冰冻切片最终证实存在以管状和实性方式生长的非典型细胞,其细胞质呈嗜酸性。肿瘤呈膨胀性生长模式,与正常肝细胞直接接触,微血管丰富,仅有稀疏的玻璃样变间隔,且无苍白细胞。免疫组化显示肿瘤细胞CD10、CD117和E-钙黏蛋白呈阳性,CK7和PAX8呈阴性,从而诊断为肝脏转移性嫌色肾细胞癌(chRCC)。精氨酸酶-1免疫组化清晰地划分了chRCC细胞与正常肝细胞之间的边界。诊断医师应注意,尽管chRCC肿瘤内血流丰富,但其恶性程度较低,且常常会给影像学和病理诊断带来困难。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5502/10407264/25ce31cd9a8f/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5502/10407264/eb69080b1079/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5502/10407264/8b0dd4c93dd7/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5502/10407264/d617b9af16a4/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5502/10407264/25ce31cd9a8f/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5502/10407264/eb69080b1079/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5502/10407264/8b0dd4c93dd7/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5502/10407264/d617b9af16a4/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5502/10407264/25ce31cd9a8f/gr4.jpg

相似文献

1
Eosinophilic variant of chromophobe renal cell carcinoma metastasizing to the liver: Diagnostic pitfall.转移至肝脏的嫌色细胞肾细胞癌嗜酸性变:诊断陷阱。
Radiol Case Rep. 2023 Jul 27;18(10):3504-3508. doi: 10.1016/j.radcr.2023.07.006. eCollection 2023 Oct.
2
DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma.DOG1、细胞周期蛋白D1、细胞角蛋白7、CD117和波形蛋白是鉴别嫌色性肾细胞癌与透明细胞肾细胞癌及肾嗜酸细胞瘤的有用免疫组化标志物。
Pathol Res Pract. 2015 Apr;211(4):303-7. doi: 10.1016/j.prp.2014.12.014. Epub 2014 Dec 30.
3
Morphological, immunohistochemical, and chromosomal analysis of multicystic chromophobe renal cell carcinoma, an architecturally unusual challenging variant.多囊性嫌色肾细胞癌的形态学、免疫组织化学及染色体分析,一种结构异常且具有挑战性的变异型。
Virchows Arch. 2016 Dec;469(6):669-678. doi: 10.1007/s00428-016-2022-x. Epub 2016 Sep 15.
4
Classic Chromophobe Renal Cell Carcinoma Incur a Larger Number of Chromosomal Losses Than Seen in the Eosinophilic Subtype.经典型嫌色性肾细胞癌比嗜酸性亚型发生更多的染色体缺失。
Cancers (Basel). 2019 Oct 3;11(10):1492. doi: 10.3390/cancers11101492.
5
Sporadic oncocytic tumors with features intermediate between oncocytoma and chromophobe renal cell carcinoma: comprehensive clinicopathological and genomic profiling.散发性具有嗜酸性细胞瘤和嫌色细胞肾细胞癌之间特征的肿瘤:全面的临床病理和基因组分析。
Hum Pathol. 2020 Oct;104:18-29. doi: 10.1016/j.humpath.2020.07.003. Epub 2020 Jul 13.
6
The Role of Genetic Analysis in Correct Diagnosis of Eosinophilic Variant of Chromophobe Renal Cell Carcinoma.遗传分析在嗜酸性细胞型肾嫌色细胞癌正确诊断中的作用。
Anticancer Res. 2020 Dec;40(12):6863-6867. doi: 10.21873/anticanres.14708.
7
Diagnostic utility of vimentin, CD117, cytokeratin-7 and caveolin-1 in differentiation between clear cell renal cell carcinoma, chromophobe renal cell carcinoma and oncocytoma.波形蛋白、CD117、细胞角蛋白-7和小窝蛋白-1在透明细胞肾细胞癌、嫌色肾细胞癌和嗜酸细胞瘤鉴别诊断中的应用价值
J Microsc Ultrastruct. 2017 Apr-Jun;5(2):90-96. doi: 10.1016/j.jmau.2016.07.005. Epub 2016 Jul 26.
8
[Pigmented microcystic chromophobe renal cell carcinoma: a clinicopathologic analysis of five cases].[色素沉着性微囊性嫌色性肾细胞癌:5例临床病理分析]
Zhonghua Bing Li Xue Za Zhi. 2018 Dec 8;47(12):926-930. doi: 10.3760/cma.j.issn.0529-5807.2018.12.006.
9
[Diagnostic utility of immunohistochemistry in differential diagnosis of renal tumors with oncocytic features].免疫组织化学在具有嗜酸性特征的肾肿瘤鉴别诊断中的诊断效用
Zhonghua Bing Li Xue Za Zhi. 2016 Oct 8;45(10):692-697. doi: 10.3760/cma.j.issn.0529-5807.2016.10.005.
10
CD10+ and CK7/RON- immunophenotype distinguishes renal cell carcinoma, conventional type with eosinophilic morphology from its mimickers.CD10+以及CK7/RON-免疫表型可将具有嗜酸性形态的传统型肾细胞癌与其模仿者区分开来。
Appl Immunohistochem Mol Morphol. 2012 Oct;20(5):454-61. doi: 10.1097/PAI.0b013e31823fecd3.

本文引用的文献

1
Clinical activity of nivolumab in patients with non-clear cell renal cell carcinoma.尼伏鲁单抗治疗非透明细胞肾细胞癌患者的临床活性。
J Immunother Cancer. 2018 Jan 29;6(1):9. doi: 10.1186/s40425-018-0319-9.
2
Phase II Trial and Correlative Genomic Analysis of Everolimus Plus Bevacizumab in Advanced Non-Clear Cell Renal Cell Carcinoma.依维莫司联合贝伐单抗治疗晚期非透明细胞肾细胞癌的II期试验及相关基因组分析
J Clin Oncol. 2016 Nov 10;34(32):3846-3853. doi: 10.1200/JCO.2016.67.9084.
3
Classification of painful bone metastases as mild, moderate, or severe using both EORTC QLQ-C15-PAL and EORTC QLQ-BM22.
使用欧洲癌症研究与治疗组织生活质量问卷C15疼痛性骨转移模块(EORTC QLQ-C15-PAL)和欧洲癌症研究与治疗组织骨转移问卷22(EORTC QLQ-BM22)将疼痛性骨转移分为轻度、中度或重度。
Support Care Cancer. 2016 Dec;24(12):4871-4878. doi: 10.1007/s00520-016-3341-9. Epub 2016 Jul 27.
4
First-line treatment with sunitinib for type 1 and type 2 locally advanced or metastatic papillary renal cell carcinoma: a phase II study (SUPAP) by the French Genitourinary Group (GETUG)†.舒尼替尼作为 1 型和 2 型局部晚期或转移性乳头状肾细胞癌的一线治疗:法国泌尿生殖系统肿瘤学组(GETUG)的一项 II 期研究(SUPAP)。
Ann Oncol. 2015 Jun;26(6):1123-1128. doi: 10.1093/annonc/mdv149. Epub 2015 Mar 23.
5
Chromophobe renal cell carcinoma: a clinicopathologic study of 203 tumors in 200 patients with primary resection at a single institution.嫌色细胞肾细胞癌:单中心 200 例患者行初次切除术的 203 例肿瘤的临床病理研究。
Am J Surg Pathol. 2011 Jul;35(7):962-70. doi: 10.1097/PAS.0b013e31821a455d.
6
Headaches in patients with brain tumors: a study of 111 patients.脑肿瘤患者的头痛:111例患者的研究
Neurology. 1993 Sep;43(9):1678-83. doi: 10.1212/wnl.43.9.1678.